Perspectives of physicians and medical assistants on the implementation of NAAT-based point-of-care testing for SARS-CoV-2 in primary care in Germany

Wolf, Florian; Matthes, Anni; Markwart, Robby; Bleidorn, Jutta

doi:10.1016/j.zefq.2022.09.006

Cited by 5 publications

(4 citation statements)

References 13 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Interestingly, a primary care study using lateral flow tests also noted a trend in reduced antibiotic prescriptions in children presenting a sore throat score over 3 and noted that prescriptions were provided due to a lack of trust in the lateral test result [ 21 ]. In this study, both patients and doctors trusted the outcome of the rapid molecular test, which corresponds to opinions and attitudes observed in earlier studies carried out in primary care sectors [ 14 , 15 , 16 ].…”

Section: Discussionsupporting

confidence: 81%

“…The uptake of POC testing has been slow in primary care, and a study undertaken in Ireland [ 13 ] revealed that GPs perceive point-of-care tests as beneficial and would welcome their use in routine clinical practice, citing guidance in decision making as the primary benefit (43%), followed by reduced referral rates (29%) and assistance in diagnosis (13%) [ 13 ]. Moreover, during the COVID-19 pandemic, studies in primary care practices in Germany and the United Kingdom using molecular testing reported patient satisfaction in terms of prompt testing and trusted results, reduced further testing and improved workflow and better patient care for high-risk groups [ 14 , 15 , 16 ].…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Does the Addition of Point-of-Care Testing Alter Antibiotic Prescribing Decisions When Patients Present with Acute Sore Throat to Primary Care? A Prospective Test of Change

Daniels,

Miles,

Button

2024

Diagnostics

View full text Add to dashboard Cite

Accurate clinical diagnosis of patients presenting to primary care settings with acute sore throat remains challenging, often resulting in the over-prescribing of antibiotics. Using point-of-care tests (POCTs) to differentiate between respiratory infections is well-accepted, yet evidence on the application within primary care is sparse. We assessed the application of testing patients (n = 160) from three family practices with suspected Streptococcal infections using rapid molecular tests (ID NOW Strep A2, Abbott). In addition to comparing clinical evaluation and prescription rates with either usual care or testing, patients and staff completed a questionnaire about their experience of molecular POCT in primary care. The immediate availability of the result was important to patients (100%), and staff (≈90%) stated that molecular testing improved the quality of care. Interestingly, only 22.73% of patients with a Centor score > 2 tested positive for Strep A and, overall, less than 50% of Centor scores 3 and 4 tested positive for Strep A with the ID NOW testing platform. The addition of rapid molecular POCTs to clinical assessment resulted in a 55–65% reduction in immediate and deferred antibiotic prescriptions. The intervention was popular with patients and medical staff but was associated with increased cost and a longer appointment length.

show abstract

Section: Discussionsupporting

confidence: 81%

Section: Introductionmentioning

confidence: 99%

Does the Addition of Point-of-Care Testing Alter Antibiotic Prescribing Decisions When Patients Present with Acute Sore Throat to Primary Care? A Prospective Test of Change

Daniels,

Miles,

Button

2024

Diagnostics

View full text Add to dashboard Cite

show abstract

“…Interestingly, a primary care study using lateral flow tests also noted a trend in reduced antibiotic prescriptions in children presenting a sore throat score over 3 and noted that prescriptions were provided due to lack of trust in the lateral test result [26]. In this study both patients and doctors trusted the outcome of the rapid molecular test which corresponds to opinions and attitudes observed in earlier studies carried out in primary care sectors [14][15][16].…”

Section: Discussionsupporting

confidence: 77%

“…Among the total of 143 participants, 92 of them indicated their interest in accessing POCTs, citing guidance in decision making as the primary benefit (43%), followed by reduced referral rates (29%) and assistance in diagnosis (13%) [13]. Moreover, during the Covid-19 pandemic, studies in primary care practices in Germany and the United Kingdom using molecular testing showed patient satisfaction in terms of prompt testing and trusted results, reduced further testing and improved workflow and better patient care for high-risk groups [14][15][16].…”

Section: Introductionmentioning

confidence: 99%

Does Point of Care Testing Reduce Antibiotic Prescribing in Patients Presenting with Acute Sore Throat to Primary Care? A Prospective Test of Change

Daniels,

Miles,

Button

2024

Preprint

View full text Add to dashboard Cite

Accurate clinical diagnosis of patients presenting to primary care settings with acute sore throat remains challenging, often resulting in the over-prescribing of antibiotics. Using point-of-care tests (POCTs) to differentiate between respiratory infections is well-accepted, yet evidence on the application within primary care is sparse. We assessed the application of testing patients (n=160) from three family practices with suspected Streptococcal infections using rapid molecular tests (ID NOW Strep A2, Abbott). In addition to comparing clinical evaluation and prescription rates with either usual care or with testing, patients and staff completed a questionnaire about their experience of molecular POCT in primary care. The immediate availability of the result was important to patients (100%) and staff (≈90%) stated that molecular testing improved quality of care. Interestingly, only 22.73% of patients with a Centor score >2 tested positive for Strep A and overall, less than 50% of Centor scores 3 and 4 tested positive for Strep A with the ID NOW testing platform. The addition of rapid molecular POCTs to clinical assessment resulted in a 55- 65% reduction in immediate and deferred antibiotic prescriptions. The intervention was popular with patients and medical staff but was associated with increased cost and a longer appointment length.

show abstract

Evaluation of the EasyNAT SARS-CoV-2 assay PCR test for the diagnosis of SARS-CoV-2 infection

Fernández-Sánchez,

Martín-Bautista,

Rivas-Ruiz

et al. 2024

Journal of Virological Methods

View full text Add to dashboard Cite

Perspectives of physicians and medical assistants on the implementation of NAAT-based point-of-care testing for SARS-CoV-2 in primary care in Germany

Cited by 5 publications

References 13 publications

Does the Addition of Point-of-Care Testing Alter Antibiotic Prescribing Decisions When Patients Present with Acute Sore Throat to Primary Care? A Prospective Test of Change

Does the Addition of Point-of-Care Testing Alter Antibiotic Prescribing Decisions When Patients Present with Acute Sore Throat to Primary Care? A Prospective Test of Change

Does Point of Care Testing Reduce Antibiotic Prescribing in Patients Presenting with Acute Sore Throat to Primary Care? A Prospective Test of Change

Evaluation of the EasyNAT SARS-CoV-2 assay PCR test for the diagnosis of SARS-CoV-2 infection

Contact Info

Product

Resources

About